Health

Life Biosciences' interim Phase 1 data show ER-100 was well tolerated at Day 56, with visual-field gains in two of three glaucoma participants — a tiny, uncontrolled first look at epigenetic reprogramming in people.

Life Biosciences will present first-in-human Phase 1 data for ER-100, the first partial epigenetic reprogramming therapy in people, at Eyecelerator on October 8.

Ultimate Longevity Center announced a 50-location Australian rollout on September 23, pushing its global footprint past 300 territories.

Fresh off a sold-out LA debut, Gary Brecka and Ultimate Longevity Center announced free events in Boulder and Denver on October 4 — as legal disputes with former partner Cardone Ventures continue in the background.

At the TIME100 Health Leadership Forum on September 10, David Sinclair defended his claim that the first 150-year-old is alive today — while warning that unproven peptide and drug self-experimentation is going mainstream.

The Blueprint founder adopted a Belgian Malinois puppy named Katara on August 20, citing research linking dog ownership to a roughly 24% lower risk of early death — his simplest longevity intervention yet.

Gary Brecka will headline "The Future of Longevity" on August 16 at LA's Peacock Theater, hosted by Sequel Brands' Ultimate Longevity Center — a public showcase for a franchise that sold 200 territories before opening a location.

In an August 8 Fox News interview, Bryan Johnson defended his claim of cloning himself "as a newborn," explaining plans to test therapies and grow organs. Scientists say human cloning isn't possible and call the framing misleading.